Latest Market News

EnergyX’s share price hike to US$11 signals renewed investor confidence and a lithium market rebound, increasing Pantera Lithium’s holding value by A$5.4 million.

RAS Technology Holdings has landed a significant contract to provide racing data and managed trading services for LeoVegas Group’s UK brands, including BetMGM UK, marking a strategic expansion into regulated markets.

Stakk Limited has reported a record-breaking $575,000 in revenue for October 2025, marking a staggering 146% increase from the previous month and nearly 9,500% growth year-over-year.

FBR Limited has inked a non-binding Memorandum of Understanding with Fraser Lyne Constructions for the sale of a Hadrian® bricklaying robot unit valued at A$7.8 million, aiming to tackle New South Wales' housing shortage with advanced automation.

ARC Funds Limited has strategically acquired $2.15 million face value of convertible notes in ausbiz TV at just 20% of their value, issuing 4.47 million new shares as consideration. This move aligns with ARC’s growth strategy to diversify income streams and deepen its investment platform.

BPH Global has locked in a six-month exclusive agreement to evaluate a proprietary ginseng-based formulation aimed at enhancing male vitality, signaling a strategic push into Traditional Chinese Medicine-inspired wellness products.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Austral Resources Australia Ltd has successfully completed a $40 million capital raise and is reinstated to ASX trading, positioning itself as a mid-tier copper producer with a dual-hub operation in Queensland.

Artrya secures participation from Mass General Brigham, a leading U.S. cardiovascular research center, in its pivotal SAPPHIRE Study launching in early 2026. This collaboration aims to validate Artrya’s AI-powered Salix platform for earlier and more effective coronary artery disease detection.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

TPG Telecom has announced a substantial special dividend and capital reduction totaling approximately AUD 3 billion, pending shareholder approval at the upcoming EGM.

Petratherm Limited reports robust metallurgical results from its Rosewood Titanium Heavy Mineral Sands Project, highlighting high-quality heavy mineral concentrates and promising recoveries that reinforce the project’s potential.